Abstract
AbstractAlzheimer's disease (AD) is a progressive neurodegenerative disease with an insidious onset that seriously affects human health. Plant‐derived peptides have been found to hinder the development of AD pathologies, which is an excellent candidate for preventing AD. However, due to the excessively complicated pathogenesis of AD and the fact that most studies on the activity of plant‐derived peptides are single and not deep enough, which restricted the development and application of plant‐derived AD‐prevention peptides (PADPs). This review summarized the currently available means of obtaining PADPs, in vitro and in vivo AD‐prevention activity validation protocols, molecular pathways of PADPs, the structure–activity relationship between plant‐derived peptides and AD‐prevention activity, and some perspectives of current advanced technologies. This paper will help to develop the foundation for the production and exploitation of PADPs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
